Life Technologies to out-license CHO cell lines recombinant proteins

- Last updated on GMT

Related tags: Medicine, Chinese hamster ovary cell

Life Technologies has concluded license agreements, providing rights to its proprietary Chinese hamster ovary (CHO) cell lines for production of recombinant proteins used as therapeutic agents and vaccines.

The biotechnology tools company counts Advanced BioScience Laboratories, CAN Development, and Chong Kun Dang Pharmaceutical as just a few of its new licensees. Commercial use rights have also been granted to selected institutions currently using the cell lines for R&D.

The program comes as part of a new out-licensing strategy, providing intellectual property rights for recombinant proteins produced for the growing markets of bioproduction, therapeutics, diagnostics, veterinary medicine and vaccines.

The company claim its CHO lines provide protein manufacturers with good yields, reduce serum-associated risks, and contain no standard pathogens, and so are suitable for therapeutic manufacturing,

“This new global licensing program is a stellar example of one of the creative ways in which the company plans to provide broader access to the company’s intellectual property,” commented Paul Grossman, Senior vice president of strategy and corporate development at Life Technologies.

“[This] includes patents, biologics materials, trademarks and trade-secrets, which are designed to lead to revolutionary developments in drug and vaccine manufacture to ultimately improve healthcare,” he added.

Related news

Show more

Related products

show more

A Culture of Innovation as a Differentiation

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Related suppliers

Follow us